Clinical Trial

REward SYSTem in Autism Spectrum Disorder and Addictive Disorder

Study acronym: RESYSTAA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 6, 2024 (before its estimated July 27, 2026 completion). Its status may not reflect the trial's current state.
Summary
An MRI Study in Subjects with Autism Spectrum Disorder and Subjects with Food Addictive Disorder compared to healthy volunteers.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-05-20; most recent amendment 2024-12-03.
Status change: Not Yet Recruiting → Recruiting 2023-07-28
Trial Details
NCT Number NCT05391113
Lead Sponsor University Hospital, Tours
Collaborators: INSERM UMR-1253, Tours, France
Conditions Autism Spectrum Disorder
Enrollment 78 participants
Start Date 2023-07-27
Primary Completion 2026-07-27 (estimated)
Study Completion 2027-01-27 (estimated)
Updated on ClinicalTrials.gov 2024-12-06